Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 14Active not recruiting 9Recruiting 7Terminated 2Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 3Oropharyngeal Neoplasms 2Lymphoma, Follicular 2Glioblastoma 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasms 1Lymphoma 1Lung Neoplasms 1Locally Recurrent Skin Squamous Cell Carcinoma 1HTLV-I Infections 1Eyelid Squamous Cell Carcinoma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Carcinoma In Situ 1Astrocytoma 1Anatomic Stage III Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

Specimen Handling 2lenvatinib 1fludarabine 1Sorafenib 1Nivolumab 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Folfox protocol 1Ethiodized Oil 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Carcinoma, Hepatocellular × Magnetic Resonance Spectroscopy × Clear all
NCT06968195 2026-04-15

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Roswell Park Cancer Institute

Phase 1 Suspended
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡